As filed with the Securities and Exchange Commission on September 16, 2020

 

Registration No. 333-       

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM S-8

 

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

 

 

 

SINTX TECHNOLOGIES, INC.

(previously known as “Amedica Corporation”)

(Exact name of registrant as specified in its charter)

 

Delaware   11-2148932
(State or other jurisdiction of   (IRS Employer
incorporation or organization)   Identification No.)

 

1885 West 2100 South

Salt Lake City, UT 84119

(Address of Principal Executive Offices)

 

SINTX Technologies, Inc. 2020 Equity Incentive Plan

(Full Title of the Plan)

 

B. Sonny Bal, President and Chief Executive Officer

SINTX Technologies, Inc.

1885 West 2100 South

Salt Lake City, UT 84119

Telephone: (801) 839-3500

(Name, Address and Telephone Number, including area code, of Agent for Service)

 

Copies of all communications, including all communications sent to agent for service should be sent to:

Kevin Ontiveros, Esq.

Life Science Law, PC

4372 W Mille Lacs Drive

South Jordan, UT 84009

Telephone: (801) 450-7001

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

(Check one):

 

Large accelerated filer [  ]   Accelerated filer[  ]
Non-accelerated filer [  ]   Smaller reporting company [X]
(Do not check if a smaller reporting company)   Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. [  ]

 

CALCULATION OF REGISTRATION FEE

 

Title of

securities to be registered

  Amount to be registered (1)   Proposed maximum offering price per share (2)     Proposed maximum aggregate offering price     Amount of registration fee  

Common Stock, $0.01 par value

per share

  1,900,000 shares   $ 1.81     $

3,439,000

    $

446.38

 

 

(1) Plus such additional indeterminable number of shares as may be required pursuant to the 2020 Equity Incentive Plan in the event of a stock dividend, stock split, recapitalization or other similar change in the Common Stock.

(2) Computed in accordance with Rules 457(c) and 457(h) under the Securities Act of 1933, as amended, such computation is based on $1.81 per share (the average of the high and low prices as reported on the NASDAQ Global Market on September 15, 2020).

 

 

 

 

 

 

PART I

 

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

 

The documents containing the information specified in “Item 1. Plan Information” and “Item 2. Registrant Information and Employee Plan Annual Information” of Form S-8 will be sent or given to participants of the SINTX Technologies, Inc. 2020 Equity Incentive Plan, as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the “Securities Act”). Such documents are not required to be, and are not, filed with the Securities and Exchange Commission either as part of this Registration Statement or as a prospectus or prospectus supplement pursuant to Rule 424 under the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of Form S-8, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3. Incorporation of Documents by Reference.

 

There are hereby incorporated by reference in this Registration Statement of SINTX Technologies, Inc. (the “Company” or the “Registrant”) (and was previously known as Amedica Corporation) the following documents and information heretofore filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) with the Securities and Exchange Commission:

 

  (a) The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019;
     
  (b) The Company’s Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2020 and June 30, 2020;
     
  (c) The Company’s Current Reports on Form 8-K filed on February 7, 2020, March 2, 2020, March 30, 2020, April 30, 2020, June 22, 2020 (with respect to Item 8.01 only), June 24, 2020, June 29, 2020, June 30, 2020, July 14, 2020, July 20, 2020, August 4, 2020, August 6, 2020, and August 14, 2020; and
     
  (d) The description of the Company’s Common Stock, which is contained in the Registration Statement on Form 8-A, as filed with the SEC on February 7, 2014, as updated by the description of our Common Stock contained in Exhibit 4.18 to our Annual Report on Form 10-K for the year ended December 31, 2019, including any amendment or report filed for the purpose of updating such description.; and.

 

All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing such documents.

 

 

 

 

The Company will provide, without charge to each person, including any beneficial owner, to whom this document is delivered, upon written or oral request of such person, a copy of any or all of the documents incorporated herein by reference (other than exhibits, unless such exhibits specifically are incorporated by reference into such documents or this document). You should direct any requests for documents to SINTX Technologies, Inc., Attention: Investor Relations, 1885 West 2100 South, Salt Lake City, Utah 84119 or by calling (801) 839-3500.

 

You also may access these filings on our website at www.sintx.com. We do not incorporate the information on our website into this prospectus supplement or the accompanying prospectus and you should not consider any information on, or that can be accessed through, our website as part of this prospectus supplement or the accompanying prospectus (other than those filings with the SEC that we specifically incorporate by reference into this prospectus supplement and the accompanying prospectus).

 

Item 4. Description of Securities.

 

Not applicable.

 

Item 5. Interests of Named Experts and Counsel.

 

Not applicable.

 

Item 6. Indemnification of Directors and Officers.

 

Section 102 of the General Corporation Law of the State of Delaware permits a corporation to eliminate the personal liability of directors of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit.

 

Section 145 of the General Corporation Law of the State of Delaware provides that a corporation has the power to indemnify a director, officer, employee, or agent of the corporation, or a person serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in related capacities against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with an action, suit or proceeding to which he was or is a party or is threatened to be made a party to any threatened, ending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.

 

 

 

 

The Registrant’s restated certificate of incorporation and restated bylaws provide that the Registrant shall indemnify, to the fullest extent authorized by the Delaware General Corporation Law, each person who is involved in any litigation or other proceeding because such person is or was a director or officer of the Registrant or is or was serving as an officer or director of another entity at the Registrant’s request, against all expense, loss or liability reasonably incurred or suffered in connection therewith. The Registrant’s restated certificate of incorporation and restated bylaws also provide that the right to indemnification includes the right to be paid expenses incurred in defending any proceeding in advance of its final disposition, provided, however, that such advance payment will only be made upon delivery to the Registrant of an undertaking, by or on behalf of the director or officer, to repay all amounts so advanced if it is ultimately determined that such director is not entitled to indemnification. If the Registrant does not pay a proper claim for indemnification in full within 60 days after the Registrant receives a written claim for such indemnification, except in the case of a claim for an advancement of expenses, in which case such period is 20 days, the Registrant’s restated certificate of incorporation and restated bylaws authorize the claimant to bring an action against the Registrant and prescribe what constitutes a defense to such action.

 

The Registrant’s restated certification of incorporation eliminates the liability of a director to the Registrant or the Registrant’s stockholders for monetary damages for such a breach of fiduciary duty as a director, except for liabilities arising:

 

  from any breach of the director’s duty of loyalty to the Registrant or its stockholders;
     
  from acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;
     
  under Section 174 or any successor provision of the Delaware General Corporation Law; or
     
  from any transaction from which the director derived an improper personal benefit.

 

The Registrant has entered into indemnification agreements with its directors and certain officers, which are in addition to the indemnification provided in the Registrant’s restated certificate of incorporation and restated bylaws, and intends to enter into indemnification agreements with any new directors and executive officers in the future. These indemnification agreements may require the Registrant, among other things, to indemnify its directors and officers for some expenses, including attorneys’ fees, judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of his or her service as one of its directors or officers, or any of the Registrant’s subsidiaries or any other company or enterprise to which the person provides services at the Registrant’s request.

 

The Registrant has purchased and intends to maintain insurance on behalf of any person who is or was a director or officer against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions.

 

The foregoing discussion of the restated certificate of incorporation, restated bylaws, indemnification agreements, indemnity agreement, and Delaware law is not intended to be exhaustive and is qualified in its entirety by such restated certificate of incorporation, restated bylaws, indemnification agreements, indemnity agreement, or law.

 

Item 7. Exemption From Registration Claimed.

 

Not applicable.

 

 

 

 

Item 8. Exhibits.

 

Exhibit

Number

  Exhibit Description  

Filed with this

Report

 

Incorporated by

Reference herein from Form or Schedule

  Filing Date  

SEC File/Reg.

Number

                     
4.1   Restated Certificate of Incorporation of the Registrant       Form 8-K (Exhibit 3.1)   2/20/14   001-33624
                     
4.1.1   Certificate of Amendment to the Restated Certificate of Incorporation of SINTX Corporation       Form 8-K (Exhibit 3.1)   1/22/16   001-33624
                     
4.1.2   Certificate of Amendment to the Restated Certificate of Incorporation of SINTX Corporation       Form 8-K (Exhibit 3.1)   11/16/17   001-33624
                     
4.1.3   Certificate of Amendment to the Restated Certificate of Incorporation       Form 8-K (Exhibit 3.1)   11/02/18   001-33624
                     
4.1.4   Certificate of Amendment to the Restated Certificate of Incorporation of SINTX Technologies, Inc.       Form 8-K (Exhibit 3.1)   7/26/19   001-33624
                     
4.2   Restated Bylaws of the Registrant       Form 8-K (Exhibit 3.1)   2/20/14   001-33624
                     
4.2.1   Amendment to the Bylaws of Amedica Corporation dated as of October 30, 2018.       Form 8-K (Exhibit 3.2)   11/02/18   001-33624
                     
4.3   Form of Common Stock Certificate of the Registrant       Amendment No. 3 to Form S-1 (Exhibit 4.1)   1/29/14   333-192232
                     
4.4   SINTX Technologies, Inc. 2020 Equity Incentive Plan   X            
                     
5.1   Opinion of Life Science Law, PC   X            
                     
23.1   Consent of Independent Registered Public Accounting Firm, Tanner LLC   X            
                     
23.2   Consent of Counsel (included in Exhibit 5.1)                
                     
24.1   Power of Attorney (included in signature page)                
                     

 

 

 

 

Item 9. Undertakings.

 

(a) The undersigned registrant hereby undertakes:

 

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the “Securities Act”);

 

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement;

 

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

 

Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are incorporated by reference in the registration statement.

 

(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

(4) That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: (i) any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; (ii) any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; (iii) the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv) any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

 

(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Salt Lake City, Utah, on this 16th day of September, 2020.

 

  SINTX TECHNOLOGIES, INC.
   
  BY: /s/ B. Sonny Bal
    B. Sonny Bal
    President and Chief Executive Officer

 

Each person whose signature appears below constitutes and appoints B. Sonny Bal and David W. Truetzel, and each of them singly, her or his true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution in each of them singly, for her or him and in her or his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8 of SINTX Technologies, Inc., and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to the attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in or about the premises, as full to all intents and purposes as she or he might or could do in person, hereby ratifying and confirming all that the attorneys-in-fact and agents or any of each of them or their substitute may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

NAME AND SIGNATURE   TITLE   DATE
         
/s/ B. Sonny Bal        
B. Sonny Bal  

Chief Executive Officer and Director

(Principal Executive Officer and Principal Financial Officer)

  September 16, 2020
         
/s/ David W. Truetzel        
David W. Truetzel   Director   September 16, 2020
         
/s/ Jeffrey S. White        
Jeffrey S. White   Director   September 16, 2020
         
/s/ Eric A. Stookey        
Eric A. Stookey   Director   September 16, 2020
         
/s/ Mark Froimson        
Mark Froimson   Director   September 16, 2020

 

 

 

 

INDEX TO EXHIBITS

 

Exhibit

Number

  Exhibit Description  

Filed with this

Report

 

Incorporated by

Reference herein from Form or Schedule

  Filing Date  

SEC File/Reg.

Number

                     
4.1   Restated Certificate of Incorporation of the Registrant       Form 8-K (Exhibit 3.1)   2/20/14   001-33624
                     
4.1.1   Certificate of Amendment to the Restated Certificate of Incorporation of SINTX Corporation       Form 8-K (Exhibit 3.1)   1/22/16   001-33624
                     
4.1.2   Certificate of Amendment to the Restated Certificate of Incorporation of SINTX Corporation       Form 8-K (Exhibit 3.1)   11/16/17   001-33624
                     
4.1.3   Certificate of Amendment to the Restated Certificate of Incorporation       Form 8-K (Exhibit 3.1)   11/02/18   001-33624
                     
4.1.4   Certificate of Amendment to the Restated Certificate of Incorporation of SINTX Technologies, Inc.       Form 8-K (Exhibit 3.1)   7/26/19   001-33624
                     
4.2   Restated Bylaws of the Registrant       Form 8-K (Exhibit 3.1)   2/20/14   001-33624
                     
4.2.1   Amendment to the Bylaws of Amedica Corporation dated as of October 30, 2018.       Form 8-K (Exhibit 3.2)   11/02/18   001-33624
                     
4.3   Form of Common Stock Certificate of the Registrant       Amendment No. 3 to Form S-1 (Exhibit 4.1)   1/29/14   333-192232
                     
4.4   SINTX Technologies, Inc. 2020 Equity Incentive Plan   X            
                     
5.1   Opinion of Life Science Law, PC   X            
                     
23.1   Consent of Independent Registered Public Accounting Firm, Tanner LLC   X            
                     
23.2   Consent of Counsel (included in Exhibit 5.1)                
                     
24.1   Power of Attorney (included in signature page)